CD8A and ovarian carcinoma: This has previously been suggested for ovarian carcinoma as well as breast cancer by numerous authors [10], [14], [28], [53], but the focus of attention has so far not been placed on the location of the cells within the examined material, but on the mere amount of CD8+ T-cells and the ratio of CD8+ to other immune cells, respectively.